Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kate Riney

Showing results (31-40 of 54) with videos related to

Pageof 6
Sort By:
Analytical Chemistry|August 8, 2017
An LC-MS/MS-Based Method for the Quantification of Pyridox(am)ine 5'-Phosphate Oxidase Activity in Dried Blood Spots from Patients with EpilepsyMatthew P Wilson, Emma J Footitt, Apostolos Papandreou, et al.
Epilepsia|May 3, 2022
ILAE classification and definition of epilepsy syndromes with onset in neonates and infants: Position statement by the ILAE Task Force on Nosology and DefinitionsSameer M Zuberi, Elaine Wirrell, Elissa Yozawitz, et al.
Epilepsia|October 5, 2022
Fenfluramine provides clinically meaningful reduction in frequency of drop seizures in patients with Lennox-Gastaut syndrome: Interim analysis of an open-label extension studyKelly G Knupp, Ingrid E Scheffer, Berten Ceulemans, et al.
Frontiers in Cellular Neuroscience|December 13, 2023
Loss of maturity and homeostatic functions in Tuberous Sclerosis Complex-derived astrocytesMark J Luinenburg, Mirte Scheper, Frederik N F Sørensen, et al.
The British Journal of Dermatology|July 18, 2023
A novel rapamycin cream formulation improves facial angiofibromas associated with tuberous sclerosis complex: a double-blind randomized placebo-controlled trialPhillip Aitken, Ioana Stanescu, Laura Boddington, et al.
Epilepsy & Behavior : E&B|October 11, 2025
Final analysis from an open-label extension study of fenfluramine for the treatment of seizures in Lennox-Gastaut syndrome: long-term impact on patients and caregiversKelly G Knupp, Ingrid E Scheffer, An-Sofie Schoonjans, et al.
Epilepsia|May 3, 2022
Methodology for classification and definition of epilepsy syndromes with list of syndromes: Report of the ILAE Task Force on Nosology and DefinitionsElaine C Wirrell, Rima Nabbout, Ingrid E Scheffer, et al.
Epilepsia|May 3, 2022
ILAE definition of the Idiopathic Generalized Epilepsy Syndromes: Position statement by the ILAE Task Force on Nosology and DefinitionsEdouard Hirsch, Jacqueline French, Ingrid E Scheffer, et al.
Journal of Clinical Medicine|June 6, 2019
Early Clinical Predictors of Autism Spectrum Disorder in Infants with Tuberous Sclerosis Complex: Results from the EPISTOP StudyRomina Moavero, Arianna Benvenuto, Leonardo Emberti Gialloreti, et al.
Epilepsia|October 23, 2025
A global perspective on transitioning from pediatric to adult care in epilepsyDanielle M Andrade, Nathalie Jetté, Ilakkiah Chandran, et al.
Pageof 6

Showing results (31-40 of 54) with videos related to

Sort By:
Pageof 6
Analytical Chemistry|August 8, 2017
An LC-MS/MS-Based Method for the Quantification of Pyridox(am)ine 5'-Phosphate Oxidase Activity in Dried Blood Spots from Patients with EpilepsyMatthew P Wilson, Emma J Footitt, Apostolos Papandreou, et al.
Epilepsia|May 3, 2022
ILAE classification and definition of epilepsy syndromes with onset in neonates and infants: Position statement by the ILAE Task Force on Nosology and DefinitionsSameer M Zuberi, Elaine Wirrell, Elissa Yozawitz, et al.
Epilepsia|October 5, 2022
Fenfluramine provides clinically meaningful reduction in frequency of drop seizures in patients with Lennox-Gastaut syndrome: Interim analysis of an open-label extension studyKelly G Knupp, Ingrid E Scheffer, Berten Ceulemans, et al.
Frontiers in Cellular Neuroscience|December 13, 2023
Loss of maturity and homeostatic functions in Tuberous Sclerosis Complex-derived astrocytesMark J Luinenburg, Mirte Scheper, Frederik N F Sørensen, et al.
The British Journal of Dermatology|July 18, 2023
A novel rapamycin cream formulation improves facial angiofibromas associated with tuberous sclerosis complex: a double-blind randomized placebo-controlled trialPhillip Aitken, Ioana Stanescu, Laura Boddington, et al.
Epilepsy & Behavior : E&B|October 11, 2025
Final analysis from an open-label extension study of fenfluramine for the treatment of seizures in Lennox-Gastaut syndrome: long-term impact on patients and caregiversKelly G Knupp, Ingrid E Scheffer, An-Sofie Schoonjans, et al.
Epilepsia|May 3, 2022
Methodology for classification and definition of epilepsy syndromes with list of syndromes: Report of the ILAE Task Force on Nosology and DefinitionsElaine C Wirrell, Rima Nabbout, Ingrid E Scheffer, et al.
Epilepsia|May 3, 2022
ILAE definition of the Idiopathic Generalized Epilepsy Syndromes: Position statement by the ILAE Task Force on Nosology and DefinitionsEdouard Hirsch, Jacqueline French, Ingrid E Scheffer, et al.
Journal of Clinical Medicine|June 6, 2019
Early Clinical Predictors of Autism Spectrum Disorder in Infants with Tuberous Sclerosis Complex: Results from the EPISTOP StudyRomina Moavero, Arianna Benvenuto, Leonardo Emberti Gialloreti, et al.
Epilepsia|October 23, 2025
A global perspective on transitioning from pediatric to adult care in epilepsyDanielle M Andrade, Nathalie Jetté, Ilakkiah Chandran, et al.
Pageof 6